Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > IOBT IO Biotech > Detailed Quotes

IOBT IO Biotech

Watchlist
2.820
+0.030+1.08%
Close  01/27 16:00 ET
High
2.904
Open
2.740
Turnover
62.28K
Low
2.740
Pre Close
2.790
Volume
21.89K
Market Cap
81.26M
P/E(TTM)
Loss
52wk High
9.770
Shares
28.82M
P/E(Static)
Loss
52wk Low
2.150
Float Cap
12.32M
Bid/Ask %
-42.86%
Historical High
17.880
Shs Float
4.37M
Volume Ratio
0.27
Historical Low
2.150
Dividend TTM
--
Div Yield TTM
--
P/B
0.53
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.50%
Amplitude
5.87%
Avg Price
2.844
Lot Size
1
Float Cap
12.32M
Bid/Ask %
-42.86%
Historical High
17.880
Shs Float
4.37M
Volume Ratio
0.27
Historical Low
2.150
Dividend TTM
--
P/B
0.53
Dividend LFY
--
Turnover Ratio
0.50%
Amplitude
5.87%
Avg Price
2.844
Lot Size
1
Price Forecast

News

Comment

Company Overview More
IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. Its platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms. The company was founded by Mai-Britt Zocca, Inge Marie Svane, and Mads Hald Andersen in December 2014 and is headquartered in Copenhagen, Denmark.
CEO: Dr. Mai-Britt Zocca, PhD
Market: NASDAQ
Listing Date: 11/05/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist